Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,455 | 1,027 | 99.1% |
| Education | $151.99 | 13 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,132 | 140 | $0 (2024) |
| Novo Nordisk Inc | $2,139 | 147 | $0 (2024) |
| PFIZER INC. | $1,061 | 89 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $976.12 | 62 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $955.84 | 44 | $0 (2024) |
| ABBVIE INC. | $906.91 | 61 | $0 (2024) |
| Lilly USA, LLC | $661.94 | 49 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $636.52 | 58 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $491.70 | 36 | $0 (2023) |
| Shire North American Group Inc | $471.87 | 25 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,461 | 74 | AstraZeneca Pharmaceuticals LP ($290.37) |
| 2023 | $2,209 | 118 | Bayer Healthcare Pharmaceuticals Inc. ($329.61) |
| 2022 | $2,274 | 135 | Novo Nordisk Inc ($412.87) |
| 2021 | $1,508 | 93 | Novo Nordisk Inc ($448.84) |
| 2020 | $2,291 | 140 | AstraZeneca Pharmaceuticals LP ($654.48) |
| 2019 | $1,993 | 141 | AstraZeneca Pharmaceuticals LP ($581.18) |
| 2018 | $2,350 | 163 | AstraZeneca Pharmaceuticals LP ($590.57) |
| 2017 | $2,519 | 176 | AstraZeneca Pharmaceuticals LP ($519.21) |
All Payment Transactions
1,040 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes Care | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Bone Health | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: VACCINES | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/06/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.21 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 10/24/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $22.21 | General |
| Category: Narcoplepsy | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Biological | ||||||
| 10/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: PAIN | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardio-renal | ||||||
| 09/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $101.23 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardio-renal | ||||||
| 08/16/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $24.40 | General |
| Category: Narcoplepsy | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Diabetes | ||||||
| 08/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 978 | 1,964 | $218,653 | $70,773 |
| 2022 | 14 | 1,081 | 1,989 | $213,551 | $68,399 |
| 2021 | 16 | 1,186 | 2,253 | $235,649 | $75,677 |
| 2020 | 14 | 1,221 | 2,437 | $233,584 | $62,303 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 217 | 533 | $137,940 | $41,343 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 231 | $42,037 | $11,831 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 36 | $9,900 | $4,002 | 40.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 202 | 438 | $7,203 | $3,671 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $4,550 | $3,132 | 68.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 31 | $2,635 | $2,230 | 84.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 190 | 413 | $4,956 | $1,397 | 28.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 21 | 21 | $2,625 | $946.11 | 36.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 31 | 31 | $1,395 | $894.97 | 64.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 100 | $4,000 | $822.37 | 20.6% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2023 | 40 | 82 | $704.00 | $336.90 | 47.9% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 19 | 22 | $706.86 | $167.28 | 23.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 486 | $125,777 | $37,241 | 29.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 136 | 247 | $43,356 | $13,051 | 30.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 57 | 57 | $4,845 | $3,904 | 80.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 36 | $9,900 | $3,692 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 22 | 22 | $3,850 | $2,710 | 70.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 58 | 58 | $2,610 | $1,576 | 60.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 194 | 402 | $4,824 | $1,379 | 28.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 33 | 36 | $2,700 | $1,259 | 46.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 201 | 409 | $6,135 | $1,212 | 19.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 22 | 32 | $4,000 | $977.06 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 56 | 92 | $3,670 | $796.93 | 21.7% |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 2022 | 40 | 79 | $782.00 | $341.47 | 43.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 17 | 20 | $581.95 | $148.94 | 25.6% |
About Dr. Mark Earhart, M.D
Dr. Mark Earhart, M.D is a Family Medicine healthcare provider based in Watkinsville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073536439.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Earhart, M.D has received a total of $16,607 in payments from pharmaceutical and medical device companies, with $1,461 received in 2024. These payments were reported across 1,040 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($16,455).
As a Medicare-enrolled provider, Earhart has provided services to 4,466 Medicare beneficiaries, totaling 8,643 services with total Medicare billing of $277,152. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Watkinsville, GA
- Active Since 07/26/2006
- Last Updated 05/11/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1073536439
Products in Payments
- FARXIGA (Drug) $2,481
- Kerendia (Drug) $955.84
- Ozempic (Drug) $920.35
- VRAYLAR (Drug) $528.66
- Livalo (Drug) $477.46
- VYVANSE (Drug) $470.89
- Vascepa (Drug) $410.67
- JARDIANCE (Drug) $398.69
- TRULICITY (Drug) $316.37
- CHANTIX (Drug) $304.83
- RYBELSUS (Drug) $297.99
- Rybelsus (Drug) $253.67
- REXULTI (Drug) $253.30
- SYMBICORT (Drug) $246.00
- UBRELVY (Drug) $242.46
- TRINTELLIX (Drug) $236.27
- MYDAYIS (Drug) $233.59
- Victoza (Drug) $226.81
- AIRSUPRA (Drug) $204.94
- LYRICA (Drug) $196.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Watkinsville
Dr. Raymond Gilbert, M.d, M.D
Family Medicine — Payments: $10,797
Dr. Thomas Mcelhannon, Md, MD
Family Medicine — Payments: $5,442
Dr. Dennis Bullock, Md, MD
Family Medicine — Payments: $3,954
Dr. Keith Zimmerman, Md, MD
Family Medicine — Payments: $2,352
Dr. Kirk Melville, Md, MD
Family Medicine — Payments: $2,257
David Gaines, Md, MD
Family Medicine — Payments: $1,129